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The thymus-speciﬁc serine protease Prss16 is highly expressed by the epithelial cells in the thymic
cortex. It has been suggested to play an important role in the positive selection of T cells through the
antigen presention pathway of the cortical antigen presenting cells. Recently, the gene ecoding Prss16
has been linked to insulin dependent diabetes mellitus (IDDM) susceptibility independent of HLA-DR3
suggesting the Prss16 may be involved in the development of autoimmune disease. Due to the
similarities of the gene structure and expression pattern between the human and mouse genes,
we compared Prss16 between non-obese diabetic (NOD) and non-obese non-diabetic (NON) mice.
Analysis of the Prss16 coding region failed to identify any differences in sequence. Northern analysis
and semi-quantitative reverse transcriptase polymerase chain reaction showed that the mRNA was
equal in size and abundance in the two strains. In situ hybridization showed similar patterns of staining.
Therefore, our data suggests that there is no signiﬁcant different in the gene structure, transcription
level, and expression pattern of Prss16 gene between NOD and NON mice.
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Type 1 or insulin-dependent diabetes mellitus (IDDM) is a
polygenic autoimmune disease caused by T cell-mediated
destruction of insulin-producing pancreatic b cells (Birk
and Cohen, 1993; Vyse and Todd, 1996). IDDM
susceptibility is most tightly associated with genes linked
to the HLA region of the Major Histocompatability
Complex (MHC) on human chromosome 6p21. The
strongest associations residewithin the HLA- DRB1, HLA-
DQA1, and HLA-DQB1 (class II) regions (Todd et al.,
1987; Nepom, 1995). However, variants in this region do
not fully explain the association between the MHC and
IDDM (Robinson et al., 1993; Lie et al., 1999a). Using
transmission disequilibrium testing, Lie et al. have shown
evidence for an IDDM susceptibility locus independent of
MHC class II located telomeric of the MHC region near
the D6S2223. The strongest candidate gene for this
susceptibility locus is Prss16, also referred to as thymus
speciﬁc serine protease (Bowlus et al., 1999).
Prss16 encodes a protein with homology to prolyl-
carboxypeptidase (PCP) and is speciﬁcally expressed by
cortical epithelial cells in the thymus. The pattern of
expression around the thymic capsule and vessels is
similar to that reported for cathepsin L, a protease
involved in antigen presentation during the positive
selection of T cells (Nakagawa et al., 1998). Similarly,
Prss16 is believed to function in the positive selection of
T cells. Defects in positive selection have been implicated
in the development of autoimmunity and IDDM, in
particular (Luhder et al., 1998).
The purpose of this study was to evaluate Prss16 as a
diabetes susceptibility locus in the non-obese diabetic
(NOD) mouse by comparison to the non-obese non
diabetic (NON) mouse. Mutations that might effect the
coding region, mRNA size and expression were screened
for by direct sequencing, Northern hybridization, semi-
quantitative real-time PCR, and in situ hybridization.
MATERIALS AND METHODS
DNA Sequencing
NON and NOD mice genomic DNA was purchased from
the Jackson Laboratory (Maine, USA). Seven pairs of
primers were designed using Primer Express software
(Applied Biosystems, Foster City, CA) for ampliﬁcation
and sequencing of all 12 exons in both strains of mice
(Table I). PCR reactions were performed under the
following conditions: 4ng/ml template DNA, 1pmol/ml
each primer, 1mM dNTPs, 1.5mM MgCl2, 1X PCR
Buffer, 0.02U/ml Taq polymerase in a ﬁnal volume of
50ml. Cycling conditions were: 948C for 3min, 35
cycles X (948C for 45s, 568C for 45s, and 728C for 1min),
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agarose gel and sequenced with the same primers on an
ABI 377 Sequencer using Big Dye Terminator Cycle
Sequencing kit (Applied Biosystems, Foster City, CA).
Sequences were aligned using Sequencher software
(Genecodes, Ann Arbor, MI).
Total RNA Isolation, Probe Labeling, and Northern
Blot Analysis
Six-week-old male C57BL/6, NOD/LtJ and NON/LtJ
mice were purchased from the Jackson Laboratory
(Maine, USA). Total RNA was prepared from the mouse
thymi using TriZol
w Reagent (Life Technologies,
Rockville, MD. USA) according to the manufacturer’s
instructions. Total RNA (10mg) was separated on
0.8% formaldehyde agarose gel and transferred onto
Hybond-Nþ nylon transfer membrane (Amersham
Pharmacia Biotech, Piscataway, NJ, USA). A mouse
cDNA clone (Genbank Accession AI587874) was
radiolabeled and hybridized as previously described.
After two washes each in 2 £ SSC, 0.1% SDS for 20min
at room temperature and 0.2 £ SSC, 0.1% SDS for
20min at 658C, the membrane was exposed to the
phosphor screen for 72h at room temperature, then
analyzed using the PhosphorImager (Molecular
Dynamics, Sunnyvale, CA, USA).
Thymic Stromal Cell Population Enrichment and Real
Time RT-PCR
Stromal cells were isolated from the thymi of 3 weeks-
old male NOD ðn ¼ 4Þ and NON ðn ¼ 4Þ mice as
previously described (French et al., 1997). Brieﬂy, fresh
thymus was cut into small pieces, suspended in RPMI
1640 (Life Technologies, Grand Island, NY, USA), and
homogenized in a loosely ﬁtting glass homogenizer. The
cell suspension was ﬁltered through a 100-mm pore cell
strainer (FALCON) and left to sediment at 48C for
10min. The supernatant was separated from the
sediment. The material retained by the strainer and
the sediment were resuspended in cold (48C) PBS and left
to sediment at 48C for 10min, and the supernatant
was separated from the sediment and the procedure was
repeated three times. The ﬁnal sediment was brieﬂy
pelleted at 800g and RNA was extracted using TriZol
w
reagent as described above.
Semi-quantitative real time PCR was performed on an
ABI 7700 Sequence Detector using SYBR
w Green Assays
(PEBiosystems,FosterCity,CA,USA.).Brieﬂy,500mgof
stromal RNA was reverse transcribed in a 20ml reaction
using SuperScript Reverse Transcriptase (Life Techno-
logies) with 2.5mM random hexamer primer (Life
Technologies) according to the manufacturer’s instruc-
tions. 5ml of 1:50 dilution of cDNA reaction was used for
template with primers TQ 295F (CAGCCACTGGATCC-
CTTCA) and TQ 262R (TGATCATTCACCCAGTA-
CCGC) in a 50ml reaction according to the manufacturer’s
recommendations. Cycling consisted of: 1 £ 508C for
2min, 1 £ 958C for 10min, 40 £ (958C for 15s, 608C for
1min). Similarly, the 18S ribosomal RNA was ampliﬁed
with primers 18S.F (CTACCACATCCAAGGAAGGCA)
and 18S.R (CAGACTTGCCCTCCAATGGA). All
samples were performed in triplicate. PCR products were
separated on a 2% agarose gel to conﬁrm speciﬁc
ampliﬁcation.QuantitationwasperformedusingSequence
Detector V1.7. A standard cDNA derived from a C57BL6
mouse thymus was used as a calibrator in each assay.
In Situ Hybridization
Mouse thymi from the NOD and NON mice were
sectioned at 8mm and ﬁxed in 4% paraformaldehyde.
Sense and antisense cRNA probes were generated from
the same cDNA clone used for Northern hybridization
with incorporation of digoxigenin-UTP (Roche Molecular
Biochemicals, Indianopolis, IN, USA). Probes were
hybridized overnight at 588C to thymic sections and
washed. Following incubation with alkaline phosphatase-
conjugated anti-digoxigenin antibody, slides were incu-
bated in BCIP/NBT at room temperature for 36h. The
sectionwere counterstained with Nuclear FastRed(Vector
Laboratories, Burlingame, CA, USA) and analyzed by
light microscopy.
RESULTS
Genomic Structure
To determine the genomic structure of the mouse Prss16
gene in both NOD and NON mice, genomic DNA
was sequenced with seven different pairs of primers.
No differences in sequence were identiﬁed between NOD
and NON.
TABLE I Primers used for ampliﬁcation and sequencing of Prss16 in NOD and NON mice
Exon(s) Forward primer Reverse primer PCR product (bp)
1,2 EX 1/2.F (GGACAAAAGAGCAGAGTGCC) EX1/2.R (AGAAAGCAAGGAACTGGGGT) 446
3,4 EX 3/4.F (GGGGGAAATCTTGGAGAAAA) EX 3/4.R (CACAGCGGTGGATACTAACAGA) 494
5–7 EX5/6/7.F (GTTACCGGAAGGAACCTTGG) EX5/6/7.R (CGCCTTCCTCCACACTCTAC) 645
8 EX 8.F (GAGGACAGGGAGTGAGGTTG) EX 8.R (TTTGGCCCATTAGTCTCTGG) 436
9 EX 9.F (GAGAAGAGGGAACATGCAGC) EX 9.R (TTCGGTTTGGGAGTTAGGTG) 241
10,11 EX 10/11.F (GAGAAGAGCAGGAGGCTGTC) EX 10/11.R (GGAGTCAGAACTCAGCACCA) 550
12 EX 12.F (GGTGCTGAGTTCTGACTCCA) EX12.R (GCCAGTCAGGATTGAGGAGA) 440
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Since NOD mice have abnormal thymic structure and
develop the autoimmune phenotype, we investigated the
thymic expression of Prss16 in NOD and NON mice.
Northern blots of NOD and NON thymus RNA were used
to screen for Prss16 mRNA level and size (Fig. 1a). No
difference in size or band intensity could be detected. We
also performed semi-quantitative PCR on thymic stromal
cells to further investigate differences in Prss16 mRNA
(Fig. 1b). When normalized to 18S rRNA, no difference in
the relative amount of Prss16 in the thymic stromal cells
from NOD and NON mice could be detected ðp . 0:70Þ:
We have previously shown by in situ hybridization that
Prss16 is much more prevalent in C57BL6 and BALB/C
than NOD thymus (Cheunsuk et al., 2002). However,
comparison of NOD to NON thymus failed to reveal any
notable difference in the pattern or density of Prss16
staining (Fig. 2).
DISCUSSION
Identiﬁcation of genetic variants that confer susceptibility
to or protection from IDDM is important to identify
high-risk individuals and potential targets for preventive
therapies. Several susceptibility loci have been identiﬁed
including the MHC class II, the INS VNTR and most
recently CTLA4 (Eaves et al., 1999; Ueda et al., 2003).
Similar inﬂuences of these loci have also been reported in
NOD mice supporting its role as a model of IDDM.
In total, more than 20 non-MHC linked genes have been
suggestedtoinﬂuencediabetessusceptibilitywiththeMHC
contributing the greatest inﬂuence (Grifﬁths et al., 1999;
Grattanetal.,2002).Mostofthiseffecthasbeenattributedto
the unusual sequence of the HLA-DQ allele in humans and
H2
g7 allele in NOD mice which both encode non-aspartic
acid residues at position 57 of the b chain. However, other
FIGURE 1 (a) Northern hybridization of Prss16 probe to total thymus RNA from C57BL/6, NOD ðn ¼ 4Þ and NON ðn ¼ 4Þ mice. (b) Prss16 mRNA
relative to 18S ribosomal RNA in thymic stromal cells from the thymi of three weeks old male NOD ðn ¼ 4Þ and NON ðn ¼ 4Þ mice. Shown is the
average and SEM for Prss16 mRNA relative to 18S rRNA.
FIGURE 2 In situ hybridization of Prss16 to thymi from NOD and
NON mice.
ANALYSIS OF PRSS16 GENE IN NOD AND NON MICE 185genetic inﬂuences linked to the MHC have been suggested
by several studies. Dissecting out the precise locus has been
difﬁcult due to the strong linkage disequilibrium in the
region. However, using transmission disequilibrium tests, a
clearassociationhasbeenestablishedintheregiontelomeric
oftheMHCclassIregiononchromosome(Lieetal.,19 99).
Notably,therateoftransmissionoftheD6S2223allele3was
0.2 in probands compared to the expected 0.5. In addition,
this same allele is associated with susceptibility to celiac
disease (Lie et al.,1 9 9 9 b ) .
Several polymorphisms in Prss16 have recently been
identiﬁed including a missense mutation and a 15 base
pair deletion (7548_7563del) predicted to result in a loss
of 5 amino acids (Lie et al., 2002). Interestingly, the
7548_7563del has an allele frequency of 0.17 and is in
linkage disequilibrium with the DQA1*05–DQB1*02
haplotype. The potential association between this and
other polymorphisms with IDDM is currently under
investigation.
In mouse, the orthologue of Prss16 is highly conserved
with expression similarly restricted to thymic cortical
epithelial cells (Cheunsuk et al., 2002). In addition,
Prss16 is expressed at lower levels in autoimmune prone
mice such as NOD and New Zealand Black (NZB) mice
compared to C57BL6 and BALB/C mice. However,
Prss16 is not syntenic to the MHC on mouse chromosome
17. Rather, it is encoded in the comparative region
centromeric of the satin (sa) locus on mouse chromosome
13. Idd14 is a diabetes susceptibility locus that has been
mapped to chromosome 13 linked to D13Mit61 (McAleer
et al., 1995). This locus was identiﬁed by an outcross of
NOD with congenic NON.H2
g7 followed by an F1
intercross. In the F2 generation, susceptibility was
associated with increased NOD homozygosity and
decreased NON homozygosity at D13Mit61.
For these reasons, we investigated Prss16 as a possible
susceptibility gene for the development of diabetes in
NOD mice. Analysis of Prss16 gene of NOD and NON
mice demonstrated no mutation in the coding sequence of
the NOD mice compare to that of the NON mice.
Previously, we have shown by in situ hybridization that
Prss16 expression in NOD mice is lower compared to
C57BL6 and Balb/c mice. In addition, lower expression is
also noted in NZB mice which are prone to autoimmune
disease as well. However, we found no difference by in
situ hybridization between NOD and NON mice. In all
strains gene expression is speciﬁc to cortical epithelial
cells. Furthermore, Northern analysis and the semiquanti-
tative PCR did not demonstrate any signiﬁcant different in
transcript size or abundance between the strains.
In conclusion, we have evaluated Prss16 as a candidate
gene for diabetes susceptibility in NOD mice. We were
unable to detect any differences in the coding sequence,
transcript size or transcript abundance. Although
we cannot conclusively rule out Prss16 as the Idd14
diabetes susceptibility gene in the NOD mouse, our results
make it highly unlikely. Interestingly, more closely linked
with D13Mit61 is cathepsin L which when deleted in mice
has been shown to result in abnormal selection of CD4þ T
cells and development of natural killer T cells (Honey
et al., 2002). Further investigation of cathepsin L as the
Idd14 susceptibility gene is warranted. It is important to
note that our results do not exclude Prss16 as a
susceptibility gene in human IDDM.
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